Vir Astellas T Cell Engager shows promise in oncology, with early data validating Vir’s shift from infectious diseases.
Browsing: Clinical Trials & R&D
Latest clinical trial results, R&D progress, study updates, and global pharma research insights.
Bayer Asundexian Stroke Prevention shows a 26% risk reduction in Phase 3 trial, boosting its commercial outlook.
AstraZeneca China investment of $15B aims to enhance drug research and development capabilities.
Alveus obesity drug secures $160M to advance into Phase 2 testing, targeting amylin and GLP-1 pathways.
Alumis TYK2 psoriasis drug shows promise with Phase 3 results, doubling shares and competing with Takeda and Johnson & Johnson.
Merck ADC trial hold affects small cell lung cancer study, with FDA citing higher than anticipated deaths.
Galapagos TYK2 drug GLPG3667 succeeds in dermatomyositis trial but misses in lupus study, impacting future partnerships.
Peanut allergy patch shows positive results in Phase 3 study, paving way for 2026 FDA submission.
Nektar autoimmune drug shows promise in alopecia study, despite missing statistical success, supporting late-stage testing.
Argenx halts two Vyvgart trials for thyroid eye disease after interim results show ineffectiveness, impacting potential market expansion.